Published in Am J Public Health on July 01, 2002
A systematic review of mental disorder, suicide, and deliberate self harm in lesbian, gay and bisexual people. BMC Psychiatry (2008) 5.82
Prevalence of non-medical drug use and dependence among homosexually active men and women in the US population. Addiction (2004) 3.01
Alcohol and tobacco use patterns among heterosexually and homosexually experienced California women. Drug Alcohol Depend (2005) 2.18
Influence of gender, sexual orientation, and need on treatment utilization for substance use and mental disorders: findings from the California Quality of Life Survey. BMC Psychiatry (2009) 1.19
Women who report having sex with women: British national probability data on prevalence, sexual behaviors, and health outcomes. Am J Public Health (2007) 1.14
Sexual orientation disparities in sexually transmitted infections: examining the intersection between sexual identity and sexual behavior. Arch Sex Behav (2012) 1.13
Do substance use norms and perceived drug availability mediate sexual orientation differences in patterns of substance use? Results from the California Quality of Life Survey II. J Stud Alcohol Drugs (2012) 1.05
The relationships of sexual identity, hazardous drinking, and drinking expectancies with risky sexual behaviors in a community sample of lesbian and bisexual women. J Am Psychiatr Nurses Assoc (2013) 1.03
Emerging Sexual Health Issues Among Women Who Have Sex with Women. Curr Infect Dis Rep (2012) 1.02
STD and HIV risk factors among U.S. young adults: variations by gender, race, ethnicity and sexual orientation. Perspect Sex Reprod Health (2012) 1.02
Sexual and drug risk behaviors among women who have sex with women. Am J Public Health (2006) 1.00
Drug use, drug severity, and help-seeking behaviors of lesbian and bisexual women. J Womens Health (Larchmt) (2006) 0.99
Research, curricula, and resources related to lesbian, gay, bisexual, and transgender health in US schools of public health. Am J Public Health (2007) 0.99
Young Thai women who use methamphetamine: intersection of sexual partnerships, drug use, and social networks. Int J Drug Policy (2008) 0.96
Sexual minority status and violence among HIV infected and at-risk women. J Gen Intern Med (2014) 0.89
Health Risk Behaviors in a Representative Sample of Bisexual and Heterosexual Female High School Students in Massachusetts. J Sch Health (2016) 0.79
Effects of sexual orientation and gender on perceived need for treatment by persons with and without mental disorders. Psychiatr Serv (2011) 0.79
HIV Risk, Health, and Social Characteristics of Sexual Minority Female Injection Drug Users in Baltimore. AIDS Behav (2015) 0.75
Risk behaviors for reproductive tract infection in women who have sex with women in Beijing, China. PLoS One (2012) 0.75
Sexual behaviors and sexually transmitted infections in a nationally representative sample of women veterans and nonveterans. J Womens Health (Larchmt) (2013) 0.75
Sexual transmission of HIV: infectiousness and prevention. AIDS (1999) 2.59
Women at a sexually transmitted disease clinic who reported same-sex contact: their HIV seroprevalence and risk behaviors. Am J Public Health (1995) 2.34
Sexual and drug-use risk factors for HIV and STDs: a comparison of women with and without bisexual experiences. Am J Public Health (1999) 1.28
Prevalence of HIV infection, sexually transmitted diseases, and hepatitis and related risk behavior in young women living in low-income neighborhoods of northern California. West J Med (2000) 1.16
Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet (2007) 13.62
Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis (2008) 6.03
Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health (2002) 6.01
Associations of race/ethnicity with HIV prevalence and HIV-related behaviors among young men who have sex with men in 7 urban centers in the United States. J Acquir Immune Defic Syndr (2004) 4.25
Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis (2002) 3.83
Unrecognized HIV infection, risk behaviors, and perceptions of risk among young men who have sex with men: opportunities for advancing HIV prevention in the third decade of HIV/AIDS. J Acquir Immune Defic Syndr (2005) 3.56
Regional patterns and correlates of substance use among young men who have sex with men in 7 US urban areas. Am J Public Health (2003) 3.22
Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health (2003) 3.03
The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities. J Infect Dis (2004) 2.76
Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort. JAMA (2005) 2.33
Effect of blood transfusion on outcome after major burn injury: a multicenter study. Crit Care Med (2006) 1.88
Knowledge of sexual partner's HIV serostatus and serosorting practices in a California population-based sample of men who have sex with men. AIDS (2006) 1.88
Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. Gastroenterology (2005) 1.75
Repeat HIV testing, risk behaviors, and HIV seroconversion among young men who have sex with men: a call to monitor and improve the practice of prevention. J Acquir Immune Defic Syndr (2002) 1.72
Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend (2005) 1.71
The psychosocial impact of testing individuals with no history of genital herpes for herpes simplex virus type 2. Sex Transm Dis (2004) 1.61
Recent patterns in population-based HIV prevalence in Swaziland. PLoS One (2013) 1.58
Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J (2004) 1.57
Public health triangulation: approach and application to synthesizing data to understand national and local HIV epidemics. BMC Public Health (2010) 1.57
Provision of syndromic treatment of sexually transmitted infections by community pharmacists: a potentially underutilized HIV prevention strategy. Sex Transm Dis (2003) 1.56
Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ (2003) 1.56
Cardiotrophin-1 reduces ischemia/reperfusion injury during liver transplant. J Surg Res (2012) 1.45
Intimate partner violence and high-risk sexual behaviors among female patients with sexually transmitted diseases. Sex Transm Dis (2002) 1.45
Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco. Sex Transm Dis (2006) 1.43
Factors in the delayed HIV presentation of immigrants in Northern California: implications for voluntary counseling and testing programs. J Immigr Minor Health (2007) 1.41
Implications of the 2013 U.S. Veterinary Workforce Study and recommendations for future actions: AVMA Workforce Advisory Group. J Am Vet Med Assoc (2013) 1.39
Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria. Transfusion (2007) 1.37
High prevalence of HIV and sexually transmitted infections among indirect sex workers in Cambodia. Sex Transm Dis (2005) 1.34
Profile of blood donors with serologic tests reactive for the presence of syphilis in São Paulo, Brazil. Transfusion (2009) 1.32
Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough. AIDS (2007) 1.31
Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians. Virol J (2010) 1.29
Risk behaviors and HIV incidence among repeat testers at publicly funded HIV testing sites in San Francisco. J Acquir Immune Defic Syndr (2002) 1.28
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors. J Clin Oncol (2004) 1.25
Pre-treatment mortality and loss-to-follow-up in HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients eligible for antiretroviral therapy in The Gambia, West Africa. AIDS Res Ther (2011) 1.24
Moderno love: sexual role-based identities and HIV/STI prevention among men who have sex with men in Lima, Peru. AIDS Behav (2013) 1.24
Recent HIV-1 infection detection: comparison of incidence estimates derived by laboratory assays and repeat testing data. J Acquir Immune Defic Syndr (2009) 1.19
Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis. J Invest Dermatol (2005) 1.18
HIV-related risk behavior among Hispanic immigrant men in a population-based household survey in low-income neighborhoods of northern California. Sex Transm Dis (2005) 1.15
Traveling young injection drug users at high risk for acquisition and transmission of viral infections. Drug Alcohol Depend (2007) 1.15
Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas. J Clin Oncol (2004) 1.13
Self-reported sexual identity, sexual behaviors and health risks. J Lesbian Stud (2003) 1.11
Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose. PLoS One (2013) 1.10
Cholinergic-dopaminergic imbalance in Pisa syndrome. Clin Neuropharmacol (2003) 1.10
The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects. Hum Mol Genet (2009) 1.09
100% adherence study: educational workshops vs. video sessions to improve adherence among ART-naïve patients in Salvador, Brazil. AIDS Behav (2008) 1.08
HIV prevalence and risk factors among fishermen in Sihanouk Ville, Cambodia. Int J STD AIDS (2004) 1.08
Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users. Epidemics (2009) 1.07
Characterization of sexually transmitted disease clinic patients with recent human immunodeficiency virus infection. J Infect Dis (2002) 1.07
Frequent hepatitis C virus superinfection in injection drug users. J Infect Dis (2004) 1.07
Characteristics of persons with recently acquired HIV infection: application of the serologic testing algorithm for recent HIV seroconversion in 10 US cities. J Acquir Immune Defic Syndr (2007) 1.06
Knock-knock: a population-based survey of risk behavior, health care access, and Chlamydia trachomatis infection among low-income women in the San Francisco Bay area. J Infect Dis (2001) 1.05
[On behalf and the extent of evidence]. Rev Med Suisse (2010) 1.04
Sexual and drug use risk behaviors among children and youth in street circumstances in Porto Alegre, Brazil. AIDS Behav (2006) 1.03
Comparison of self-reports and parent proxy-reports of function and quality of life of children with below-the-elbow deficiency. J Bone Joint Surg Am (2009) 1.02
Trends in hepatitis C and HIV infection among inmates entering prisons in California, 1994 versus 1999. AIDS (2002) 1.02
Hepatitis C virus infection in young, low-income women: the role of sexually transmitted infection as a potential cofactor for HCV infection. Am J Public Health (2002) 1.02
Gay Asian men in San Francisco follow the international trend: increases in rates of unprotected anal intercourse and sexually transmitted diseases, 1999-2002. AIDS Educ Prev (2004) 1.01
Prenatal HIV counseling and testing in California: women's experiences and providers' practices. AIDS Educ Prev (2002) 1.01
Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8. Int J Cancer (2005) 1.01
Health indicators among low income women who report a history of sex work: the population based Northern California Young Women's Survey. Sex Transm Infect (2005) 1.00
Two distinct epidemics: the rise of HIV-1 and decline of HIV-2 infection between 1990 and 2007 in rural Guinea-Bissau. J Acquir Immune Defic Syndr (2010) 0.99
Rate and predictors of repeat Chlamydia trachomatis infection among men. Sex Transm Dis (2008) 0.98
A molecular epidemiological study of var gene diversity to characterize the reservoir of Plasmodium falciparum in humans in Africa. PLoS One (2011) 0.98
Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome. Gynecol Endocrinol (2008) 0.98
Long-term female condom use among vulnerable populations in Brazil. AIDS Behav (2006) 0.98
HIV prevention fatigue among high-risk populations in San Francisco. J Acquir Immune Defic Syndr (2004) 0.97
Pathologic ventricular hypertrophy in the offspring of diabetic mothers: a retrospective study. Eur Heart J (2006) 0.97
Recent decline in the incidence of human immunodeficiency virus infection among California men who have sex with men. Am J Epidemiol (2011) 0.97
Effects of IFN-α as a signal-3 cytokine on human naïve and antigen-experienced CD8(+) T cells. Eur J Immunol (2010) 0.96
Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus. Vaccine (2002) 0.96
Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO Study. Drug Alcohol Rev (2008) 0.96
Electronic vending machines for dispensing rapid HIV self-testing kits: a case study. AIDS Care (2013) 0.95
Frequent international travel by men who have sex with men recently diagnosed with HIV-1: potential for transmission of primary HIV-1 drug resistance. J Travel Med (2008) 0.94
High levels of subgenomic HCV plasma RNA in immunosilent infections. Virology (2007) 0.93
Access to drug abuse treatment under Treatment on Demand policy in San Francisco. Am J Drug Alcohol Abuse (2007) 0.93
Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting. J Infect Dis (2005) 0.92
An evaluation of the relative sensitivities of the venereal disease research laboratory test and the Treponema pallidum particle agglutination test among patients diagnosed with primary syphilis. Sex Transm Dis (2007) 0.92
Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12. J Virol (2008) 0.92
Chlamydia trachomatis and Neisseria gonorrhoeae infections among men and women entering California prisons. Am J Public Health (2006) 0.92
Low incidence and prevalence of hepatitis C virus infection among sexually active non-intravenous drug-using adults, San Francisco, 1997-2000. Sex Transm Dis (2003) 0.91
Options for prevention of HIV transmission from mother to child, with a focus on developing countries. Paediatr Drugs (2002) 0.91
The validity of compliance monitors to assess wearing time of thoracic-lumbar-sacral orthoses in children with spinal cord injury. Spine (Phila Pa 1976) (2008) 0.91
Madelung's deformity: quantitative assessment of x-ray deformity. J Hand Surg Am (2005) 0.91
Impact of prostheses on function and quality of life for children with unilateral congenital below-the-elbow deficiency. J Bone Joint Surg Am (2006) 0.91
Real-Time PCR for detection of herpes simplex virus without nucleic acid extraction. BMC Infect Dis (2006) 0.90
HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007. Retrovirology (2010) 0.89
Incidence and prevalence of herpes simplex virus type 2 infection in persons seeking repeat HIV counseling and testing. Sex Transm Dis (2003) 0.89
IFN-alpha gene therapy for woodchuck hepatitis with adeno-associated virus: differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes. Mol Ther (2005) 0.89
Poorly soluble peptides can mimic authentic ELISPOT responses. J Immunol Methods (2004) 0.89
Impact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults. Respir Med (2005) 0.89
Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex. Vaccine (2005) 0.88
Expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension between 24 and 34 weeks' gestation. Eur J Obstet Gynecol Reprod Biol (2003) 0.87